Skip to main content

Table 1 Experimental groups used for gene expression profiling

From: Combining global genome and transcriptome approaches to identify the candidate genes of small-effect quantitative trait loci in collagen-induced arthritis

Group Treatment RNA source No. of mice CV (percentage)
DBA/1_NC None LN from naive control DBA/1 3 22.8
DBA/1_PI CFA + collagen II LN from DBA/1 at day 10 after immunisation 3 20.4
DBA/1_OA CFA + collagen II LN from DBA/1 mice at day 35 after immunisation 3 21.7
DBA/1_CA CFA + collagen II LN from DBA/1 mice at day 95 after immunisation 3 25.8
FVB/N_NC None LN from naive control FVB/N 3 21.1
FVB/N_PI CFA + collagen II LN from FVB/N at day 10 after immunisation 3 22.6
FVB/N_OA CFA + collagen II LN from FVB/N mice at day 35 after immunisation 3 18.4
FVB/N_CA CFA + collagen II LN from FVB/N mice at day 95 after immunisation 3 21.1
  1. CA, chronic arthritis; CFA; complete Freund's adjuvant; CV, coefficient of variation; LN, lymph node; NC, naive control; OA, onset of arthritis; PI, post-immunisation.